JO
CPHR

John Overdeck’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

John Overdeck’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-108,141
Closed -$980K – 3287
2015
Q1 		$980K Sell
108,141
-4,500
-4% -$56.5K ﹤0.01% 1601
2014
Q4 		$1.62M Buy
+112,641
New +$1.63M 0.01% 1127

Other funds holding CPHR

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
RA
Raffles Associates New York $117M AUM 22.1% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.3B AUM 24.01% 1-Year Est. Return

John Overdeck's CPHR Position: Q2 2015 in Review

John Overdeck sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q2 2015, closing a stake of 108,141 shares — an estimated $980K sold.

John Overdeck first reported a position in CPHR in Q4 2014 and held it in 2 quarters. The position peaked at $1.62M in Q4 2014. 25 funds tracked by Wall St. Rank hold CPHR as of Q2 2015.

  • John Overdeck reported no remaining Cipher Pharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
  • John Overdeck sold 108,141 Cipher Pharmaceuticals Inc. shares in Q2 2015, an estimated $980K.
  • John Overdeck first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 2 quarters.
  • John Overdeck's Cipher Pharmaceuticals Inc. position peaked at $1.62M in Q4 2014.
  • 25 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q2 2015.

Based on Two Sigma Investments's 13F filing for Q2 2015, filed 14 Aug 2015.